Page last updated: 2024-08-21

allylglycine and Endotoxin Shock

allylglycine has been researched along with Endotoxin Shock in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dagvadorj, J; Hiwasa, T; Iftakhar-E-Khuda, I; Koide, N; Komatsu, T; Naiki, Y; Ookoshi, M; Tumurkhuu, G; Yokochi, T; Yoshida, T1

Other Studies

1 other study(ies) available for allylglycine and Endotoxin Shock

ArticleYear
ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.
    Innate immunity, 2011, Volume: 17, Issue:1

    Topics: Allylglycine; Animals; Benzamidines; Cell Line, Tumor; Culture Media, Conditioned; Esters; Female; Gabexate; Gene Expression; Guanidines; I-kappa B Proteins; Interferon Regulatory Factor-3; Interferon-gamma; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Serine Proteases; Serine Proteinase Inhibitors; Shock, Septic; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2011